Showing results (761-770 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|December 1, 2001
[Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer.A retrospective analysis of patients treated from 1951 to 1998 in university hospital]S Klutmann, L Jenicke, M Geiss-Tönshoff, et al.Nuklearmedizin. Nuclear Medicine|December 1, 2001
Results of preoperative ultrasound guided fine needle aspiration biopsy of solitary thyroid nodules as compared with the histology. A retrospective analysis of 538 patientsP Mikosch, U Wartner, E Kresnik, et al.Nuklearmedizin. Nuclear Medicine|December 1, 2001
[Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma]K Zöphel, G Wunderlich, U Liepach, et al.Nuklearmedizin. Nuclear Medicine|July 12, 2002
[Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)]G Pöpperl, C Götz, F J Gildehaus, et al.Nuklearmedizin. Nuclear Medicine|July 12, 2002
Minimal contribution of cell-bound antibodies to the immunoscintigraphy of inflamed joints with 99mTc-anti-CD4 monoclonal antibodiesR W Kinne, A Wolski, E Palombo-Kinne, et al.Nuklearmedizin. Nuclear Medicine|June 2, 2000
Classification of the lymphatic drainage status of a primary tumour: a proposalD L Munz, S Maza, V Ivancević, et al.Nuklearmedizin. Nuclear Medicine|February 26, 2003
[Monitoring of 131I incorporation in nuclear medicine personnel by self accomplished measurements]H Hänscheid, M Lassmann, F Aulbach, et al.Nuklearmedizin. Nuclear Medicine|April 1, 1976
[Heart-blood-pool scintigraphy in dialyzed chronic uremic patients)]E S Nagy, Z Nemessányi, G NáraiNuklearmedizin. Nuclear Medicine|November 7, 2002
Excretion of FDG into saliva and its significance for PET imagingA Stahl, B Dzewas, M Schwaiger, et al.Nuklearmedizin. Nuclear Medicine|November 7, 2002
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET]S Schmidt, U Nestle, K Walter, et al.Pageof 204